|
Cancer 52 |
93 Newman Street London |
UNITED KINGDOM |
25/05/2020 |
Janssen provided Cancer52 with £12000 in core funding to continue to deliver key support services for patients during the COVID 19 Pandemic. |
- |
12 000 GBP |
0 GBP |
|
Cancer Black Care |
79 Acton Lane London |
UNITED KINGDOM |
03/04/2020 |
Janssen provided Cancer Black Care with £2,000 of core funding to further strengthen the emotional and practical support offering of people affected by cancer. |
- |
2 000 GBP |
0 GBP |
|
|
|
|
22/06/2020 |
Janssen provided Cancer Black Care with £2,000 of core funding to support their information, advocacy and support services for people living with cancer. |
- |
2 000 GBP |
0 GBP |
|
CLL Support Association |
Bath Road Chippenham |
UNITED KINGDOM |
01/06/2020 |
Janssen provided CLL Support with core funding of £7500 to to support their core activity in 2020 |
- |
7 500 GBP |
0 GBP |
|
|
|
|
01/06/2020 |
Janssen supported CLL Support Association with £7500 in core funding to continue to deliver key support services for patients during the COVID 19 Pandemic. |
- |
7 500 GBP |
0 GBP |
|
|
|
|
22/12/2020 |
Janssen provided payment of £7500 to CLL Support Association to support their core activity in 2021 |
- |
7 500 GBP |
0 GBP |
|
Crohn's & Colitis UK |
1 Bishops Square Hatfield |
UNITED KINGDOM |
11/05/2020 |
Janssen provided Crohn's and Colitis UK with £20,000 in core funding to support the delivery of key support services during the COVID-19 pandemic |
- |
20 000 GBP |
0 GBP |
|
|
|
|
13/02/2020 |
Janssen provided Crohn's & Colitis UK a fee of £420 for participation in a patient group advisory board and travel costs of £30. |
- |
0 GBP |
450 GBP |
|
|
|
|
01/06/2020 |
In 2020 Janssen provided Crohn's and Colitis UK with funding of £100,000 as part of the Not Every Disability is Visible campaign collaboration. Of this, £53,575 was paid as a contribution to CCUK costs and £46,425 was paid for agency pass-through costs |
- |
100 000 GBP |
0 GBP |
|
Down Syndrome International |
2A Langdon Park Teddington |
UNITED KINGDOM |
11/09/2020 |
Janssen provided Down Syndrome International with £15,965 in core funding towards the development of an evidence-based, cardiac consensus statement for people with Down Syndrome |
- |
15 965 GBP |
0 GBP |
|
Fight Bladder Cancer |
51 High Street Chinnor |
UNITED KINGDOM |
30/07/2020 |
Janssen provided Fight Bladder Cancer with a total of £485, of which £165 was non-financial support, to facilitate their team's learning and development and in turn better support bladder cancer patients. |
Janssen provided Fight Bladder Cancer with a total of £485, of which £165 was non-financial support, to facilitate their team's learning and development and in turn better support bladder cancer patients. |
320 GBP |
0 GBP |
|
|
|
|
08/10/2020 |
In 2020, Janssen provided Fight Bladder Cancer with £200 for their involvement in a bladder cancer advisory board |
- |
0 GBP |
200 GBP |
|
|
|
|
24/11/2020 |
- |
Janssen provided Fight Bladder Cancer with Learning and Development staff expertise on presentation style and content. This amounted to £99 in non-financial support |
0 GBP |
0 GBP |
|
|
|
|
15/06/2020 |
Janssen provided Fight Bladder Cancer with £5,000 of core funding to continue to deliver key support services for bladder cancer patients during the pandemic. |
- |
5 000 GBP |
0 GBP |
|
|
|
|
10/08/2020 |
Janssen provided £10,000 of core funding support to Fight Bladder cancer towards their awareness and information services for people living with bladder cancer. |
- |
10 000 GBP |
0 GBP |
